Delivery Order SPE2DB20D2104-SPE2DB24FV32T
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.95 firm-fixed-price delivery order is for the supply of 4,566,340,680 units of the prescription drug Vyvanse 40 mg capsules. The contract has an ultimate completion date of November 6, 2024 and was awarded on November 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award, SPE2DB22D3004|SPE2DB24FND64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,872.39 firm-fixed-price delivery order is for the supply of 4,562,463,056 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of October 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,240.18 firm fixed-price delivery order is for 4,566,727,569 units of the medication Vyvanse 40 mg capsules. The contract has a ceiling value of $3,240.18 and a completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.89 firm fixed-price delivery order is for 4,562,925,581 units of the medication Vyvanse 40 mg capsules. The contract has a completion date of November 29, 2023 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,849.36 firm-fixed-price delivery order is for the provision of 4,563,139,143 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of December 19, 2023. AmerisourceBergen is the prime contractor, with no mentioned subcontractors. This award is part of a larger $999,999,999 Indefinite...
This federal contract award, SPE2DB22D3004|SPE2DB25FQG61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,485.49 firm fixed-price delivery order is for the supply of 4,567,955,619 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 16, 2025 and does not utilize any set-aside designations, indicating open competition....
This federal contract award, valued at $12,380.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,225,719 units of the prescription drug Vyvanse 40 mg capsules over a 3-year period ending in October 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,846.39 firm-fixed-price delivery order is for the supply of 4,565,014,816 units of the medication Vyvanse 40 mg capsules. The contract has a completion date of June 26, 2024 and was awarded on June 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEJP1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,579.86 firm fixed-price delivery order is for the supply of 4,567,968,732 units of the prescription medication Vyvanse 40 mg capsules. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This award is not a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,728,779 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $2,675.40 and a period of performance through December 17, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...